PYXS Pyxis Oncology, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 13, 2026
$2,14
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$1,03rendah 52m
$5,55tinggi 52m
Kapitalisasi Pasar (MRQ)
$136M
P/E
-1.7
EPS
$-1.28
Pendapatan
$14M
lencana Anda
Rentang 52M
$1–$6
Peringkat Analis
STRONG BUY
Target Harga
$9
P/E
-1.7
ROE
-112.9%
Margin Laba Bersih
-574.5%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
PYXS Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$2.14
Kapitalisasi Pasar (MRQ)
$136M
P/E
-1.7
EPS
$-1.28
Pendapatan
$14M
ROE
-112.9%
Rentang 52M
$1–$6
PYXS Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$14M2024-12-31 → 2025-12-31
EPS$-1.282021-12-31 → 2025-12-31
Arus Kas Bebas$-64M2021-12-31 → 2025-12-31
Margin bersih-574.5%2024-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | PYXS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -1.7rata-rata 5T ≈-0.9 | ≈-0.9 | · | · | |
| P/S | 9.7 | · | 4.9 | Nilai wajar | |
| P/B (MRQ) | 11.9rata-rata 5T ≈1.0 | ≈1.0 | 2.8 | Terlalu mahal | |
| Price / FCF (Harga / FCF) | -2.1rata-rata 5T ≈-3.4 | ≈-3.4 | · | · | |
| Price / Cash Flow (Harga / Arus Kas) | -2.1rata-rata 5T ≈-3.5 | ≈-3.5 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 2.5rata-rata 5T ≈0.9 | ≈0.9 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | PYXS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Operating Margin (Margin Operasi) | -609.2% | · | -226.0% | Lemah | |
| EBITDA Margin (Margin EBITDA) | -576.6% | · | -226.0% | Lemah | |
| Pretax Margin (Margin Sebelum Pajak) | -564.6% | · | -398.8% | Di bawah rata-rata | |
| Net Profit Margin (Margin Laba Bersih) | -574.5% | · | -220.0% | Lemah | |
| ROA | -64.0%rata-rata 5T ≈-50.4% | ≈-50.4% | -34.3% | Lemah | |
| ROE | -112.9%rata-rata 5T ≈-76.3% | ≈-76.3% | -61.9% | Lemah | |
| ROIC | -160.9% | · | -67.3% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | PYXS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 1.3rata-rata 5T ≈7.7 | ≈7.7 | 7.5 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 3.2rata-rata 5T ≈7.4 | ≈7.4 | 7.1 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | PYXS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | -14.2% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | PYXS | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.1 | · | 0.1 | Lemah | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$247.5K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
4.3%
Laporan Berikutnya
Nov 02, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 19, 2026 | $-0.40 | $-0.36 | -11.0% |
| 31 Maret 2026 | Mei 14, 2026 | $-0.37 | $-0.38 | 1.7% |
| 31 Des. 2025 | $-0.29 | $-0.34 | 15.6% | |
| 30 Sep. 2025 | $-0.35 | $-0.35 | -1.4% | |
| 30 Juni 2025 | $-0.30 | $-0.36 | 16.4% | |
| 31 Maret 2025 | $-0.35 | $-0.30 | -16.7% | |
| 31 Des. 2024 | $-0.25 | $-0.34 | 25.7% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Revenue | $14M | $16M | |
| Cost of Revenue | $2M | $475.0K | |
| R&D Expense | $74M | $59M | |
| SG&A Expense | $22M | $25M | |
| Operating Income | $-84M | $-89M | |
| Interest Income | $650.0K | $930.0K | |
| Other Non-op | $6M | $10M | |
| Pretax Income | $-78M | $-79M | |
| Income Tax | $1M | $-2M | |
| Net Income | $-80M | $-77M | |
| EPS (Basic) | $-1.28 | $-1.32 | |
| EPS (Diluted) | $-1.28 | $-1.32 | |
| Shares (Basic) | 62,143,166 | 58,445,765 | |
| Shares (Diluted) | 62,143,166 | 58,445,765 | |
| EBITDA | $-80M | $-86M |
Neraca
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $15M | $19M | |
| Short-term Investments | $51M | $107M | |
| Prepaid Expense | $4M | $4M | |
| Other Current Assets | $626.0K | $434.0K | |
| Current Assets | $72M | $132M | |
| PP&E (Net) | $8M | $10M | |
| PP&E (Gross) | $15M | $15M | |
| Accum. Depreciation | $7M | $5M | |
| Intangibles | $0 | $3M | |
| Total Assets | $92M | $157M | |
| Accounts Payable | $11M | $5M | |
| Accrued Liabilities | $9M | $11M | |
| Current Liabilities | $21M | $18M | |
| Capital Leases | $17M | $19M | |
| Deferred Tax | · | $0 | |
| Total Liabilities | $38M | $36M | |
| Common Stock | $63.0K | $60.0K | |
| Paid-in Capital | $496M | $484M | |
| Retained Earnings | $-443M | $-364M | |
| AOCI | $53.0K | $170.0K | |
| Stockholders' Equity | $53M | $121M | |
| Liabilities + Equity | $92M | $157M | |
| Shares Outstanding | 62,690,229 | 59,967,814 |
Arus Kas
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| D&A | $5M | $3M | |
| Stock-based Comp | $12M | $13M | |
| Deferred Tax | $0 | $-2M | |
| Other Non-cash | $-193.0K | $4M | |
| Operating Cash Flow | $-64M | $-58M | |
| CapEx | $9.0K | $237.0K | |
| Investing Cash Flow | $59M | $8M | |
| Financing Cash Flow | $594.0K | $59M | |
| Net Change in Cash | $-4M | $10M | |
| Taxes Paid | $1M | $164.0K | |
| Free Cash Flow | $-64M | $-58M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -609.2% | -554.1% | |
| Net Margin | -574.5% | -479.0% | |
| Pretax Margin | -564.6% | -492.3% | |
| EBITDA Margin | -576.6% | -535.6% | |
| ROA | -64.0% | -46.7% | |
| ROE | -112.9% | -56.4% | |
| ROIC | -160.9% | -72.1% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 3.4 | 7.5 | |
| Quick Ratio | 3.2 | 7.2 |
Efisiensi
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 |
Per Saham
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Book Value / Share | $0.85 | $2.01 | |
| Revenue / Share | $0.22 | $0.28 | |
| Cash Flow / Share | $-1.02 | $-0.99 | |
| Cash / Share | $0.25 | $0.32 | |
| EPS (TTM) | $-1.28 | $-1.32 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | -14.2% | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $14M | $16M | |
| Net Income TTM | $-80M | $-77M | |
| Market Cap | $72M | $94M | |
| P/E | -0.9 | -1.2 | |
| P/S | 5.2 | 5.8 | |
| P/B | 1.3 | 0.8 | |
| P / Tangible Book | 1.3 | 0.8 | |
| P / Cash Flow | -1.1 | -1.6 | |
| P / FCF | -1.1 | -1.6 | |
| Earnings Yield | -111.3% | -84.6% |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $11M | $0 | $3M | · | $0 | $0 | $0 | $16M | |
| Cost of Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $475.0K | |
| R&D Expense | $16M | $20M | $22M | $18M | $17M | $17M | $14M | $18M | $14M | $13M | |
| SG&A Expense | $10M | $4M | $5M | $6M | $5M | $6M | $5M | $6M | $6M | $8M | |
| Operating Expenses | $26M | $24M | · | · | $23M | $23M | · | · | · | · | |
| Operating Income | $-26M | $-24M | $-18M | $-23M | $-20M | $-23M | $-40M | $-24M | $-20M | $-6M | |
| Interest Income | $61.0K | $218.0K | $225.0K | $242.0K | $99.0K | $84.0K | $87.0K | $194.0K | $387.0K | $262.0K | |
| Other Non-op | $644.0K | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $2M | |
| Pretax Income | $-25M | · | $-17M | $-22M | $-18M | · | $-38M | $-21M | $-17M | · | |
| Income Tax | $0 | · | $1M | $0 | $283.0K | · | · | · | · | · | |
| Net Income | $-25M | $-23M | $-18M | $-22M | $-18M | $-21M | $-36M | $-21M | $-17M | $-3M | |
| EPS (Basic) | $-0.40 | $-0.37 | $-0.28 | $-0.35 | $-0.30 | $-0.35 | $-0.62 | $-0.35 | $-0.29 | $-0.06 | |
| EPS (Diluted) | $-0.40 | $-0.37 | $-0.28 | $-0.35 | $-0.30 | $-0.35 | $-0.62 | $-0.35 | $-0.29 | $-0.06 | |
| Shares (Basic) | 63,991,609 | 63,469,850 | · | 62,557,386 | 61,918,826 | 61,048,948 | · | 60,715,041 | 60,495,675 | 51,289,284 | |
| Shares (Diluted) | 63,991,609 | 63,469,850 | · | 62,557,386 | 61,918,826 | 61,048,948 | · | 60,715,041 | 60,495,675 | 51,289,284 | |
| EBITDA | $-26M | $-24M | · | $-23M | $-20M | $-22M | · | $-24M | $-20M | $-4M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $6M | $15M | $9M | $11M | $13M | $19M | $12M | $25M | $28M | |
| Short-term Investments | $14M | $35M | $51M | $67M | $78M | $93M | $107M | $133M | $131M | $129M | |
| Receivables | · | · | · | · | $3M | · | · | · | · | $8M | |
| Prepaid Expense | $2M | $3M | $4M | $5M | $7M | $5M | $4M | $3M | $4M | $6M | |
| Other Current Assets | · | · | $626.0K | · | · | · | $434.0K | · | · | · | |
| Current Assets | $37M | $46M | $72M | $83M | $100M | $112M | $132M | $149M | $161M | $172M | |
| PP&E (Net) | $7M | $8M | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $15M | · | · | · | |
| Accum. Depreciation | · | · | $7M | · | · | · | $5M | · | · | · | |
| Intangibles | · | · | $0 | $2M | $2M | $3M | $3M | $24M | $24M | $24M | |
| Total Assets | $55M | $64M | $92M | $106M | $123M | $136M | $157M | $195M | $208M | $220M | |
| Accounts Payable | $3M | $5M | $11M | $10M | $9M | $3M | $5M | $5M | $5M | $2M | |
| Accrued Liabilities | $12M | $10M | $9M | $8M | $7M | $10M | $11M | $14M | $10M | $11M | |
| Current Liabilities | $27M | $17M | $21M | $19M | $18M | $14M | $18M | $20M | $17M | $14M | |
| Capital Leases | $16M | $16M | $17M | $17M | $18M | $18M | $19M | $19M | $19M | $20M | |
| Deferred Tax | · | · | · | · | · | · | · | $2M | $2M | $2M | |
| Total Liabilities | $43M | $33M | $38M | $37M | $36M | $33M | $36M | $42M | $39M | $36M | |
| Common Stock | $63.0K | $63.0K | $63.0K | $62.0K | $62.0K | $62.0K | $60.0K | $59.0K | $59.0K | $59.0K | |
| Paid-in Capital | $503M | $498M | $496M | $494M | $491M | $488M | $484M | $481M | $477M | $474M | |
| Retained Earnings | $-492M | $-466M | $-443M | $-425M | $-403M | $-385M | $-364M | $-328M | $-307M | $-289M | |
| AOCI | $-4.0K | $0 | $53.0K | $69.0K | $-5.0K | $49.0K | $170.0K | $351.0K | $-102.0K | $-60.0K | |
| Stockholders' Equity | $11M | $31M | $53M | $69M | $88M | $103M | $121M | $154M | $170M | $184M | |
| Liabilities + Equity | $55M | $64M | $92M | $106M | $123M | $136M | $157M | $195M | $208M | $220M | |
| Shares Outstanding | 63,434,936 | 62,831,246 | 62,690,229 | 62,149,664 | 62,018,135 | 61,631,376 | 59,967,814 | 59,449,998 | 58,914,712 | 58,803,126 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $301.0K | $459.0K | $3M | $527.0K | $535.0K | $552.0K | $550.0K | $731.0K | $585.0K | $1M | |
| Stock-based Comp | $6M | $1M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $4M | |
| Other Non-cash | · | $-4M | · | · | · | $-6M | · | · | · | $-23M | |
| Operating Cash Flow | $-18M | $-26M | $-10M | $-13M | $-17M | $-23M | $-19M | $-15M | $-3M | $-21M | |
| CapEx | · | · | $0 | · | · | · | $0 | $0 | $0 | $237.0K | |
| Investing Cash Flow | $21M | $16M | $16M | $11M | $15M | $16M | $27M | $-8.0K | $4.0K | $-18M | |
| Financing Cash Flow | $10M | $-25.0K | $669.0K | $-8.0K | $-67.0K | $0 | $50.0K | $2M | $110.0K | $58M | |
| Net Change in Cash | $13M | $-10M | $7M | $-2M | $-2M | $-7M | $7M | $-13M | $-3M | $18M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-21M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -700.4% | · | · | · | · | -34.7% | |
| Net Margin | · | · | · | · | -650.9% | · | · | · | · | -20.2% | |
| Pretax Margin | · | · | · | · | -640.8% | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | -700.4% | · | · | · | · | -27.8% | |
| ROA | -28.5% | -23.2% | · | -14.6% | -11.1% | -11.9% | · | -11.1% | -9.0% | -1.6% | |
| ROE | -51.2% | -34.6% | · | -19.8% | -14.3% | -14.7% | · | -14.5% | -11.0% | -1.9% | |
| ROIC | -227.2% | · | · | · | -22.9% | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 2.8 | · | 4.3 | 5.7 | 7.8 | · | 7.3 | 9.5 | 12.2 | |
| Quick Ratio | 1.2 | 2.5 | · | 3.9 | 5.2 | 7.3 | · | 7.1 | 9.2 | 11.7 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | · | · | · | · | 0.1 | |
| Receivables Turnover | · | · | · | · | 1.9 | · | · | · | · | 4.0 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.18 | $0.50 | · | $1.11 | $1.41 | $1.67 | · | $2.58 | $2.88 | $3.13 | |
| Revenue / Share | · | · | · | · | $0.05 | · | · | · | · | $0.31 | |
| Cash Flow / Share | · | $-0.41 | · | · | · | $-0.37 | · | · | · | $-0.40 | |
| Cash / Share | $0.30 | $0.09 | · | $0.14 | $0.17 | $0.21 | · | $0.20 | $0.43 | $0.48 | |
| EPS (TTM) | $-1.40 | $-1.30 | · | $-1.62 | $-1.62 | $-1.61 | · | $-1.04 | $-1.25 | $-1.37 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | $16M | · | · | · | · | |
| Net Income TTM | $-89M | $-82M | · | $-97M | $-96M | $-95M | · | $-57M | $-59M | $-58M | |
| Market Cap | $191M | $92M | · | $138M | $68M | $60M | · | $218M | $195M | $251M | |
| P/E | -2.1 | -1.1 | · | -1.4 | -0.7 | -0.6 | · | -3.5 | -2.6 | -3.1 | |
| P/S | · | · | · | · | · | 3.7 | · | · | · | · | |
| P/B | 16.7 | 2.9 | · | 2.0 | 0.8 | 0.6 | · | 1.4 | 1.1 | 1.4 | |
| P / Tangible Book | 16.7 | 2.9 | · | 2.1 | 0.8 | 0.6 | · | 1.7 | 1.3 | 1.6 | |
| P / Cash Flow | · | -3.5 | · | · | · | -2.7 | · | · | · | -12.1 | |
| Earnings Yield | -46.5% | -89.0% | · | -73.0% | -147.3% | -164.3% | · | -28.3% | -37.8% | -32.2% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $14M | $16M | · | · | · |
| Margin Operasi % | -609.2% | -554.1% | · | · | · |
| Laba Bersih | $-80M | $-77M | $-74M | $-121M | $-76M |
| EPS Dilusian | $-1.28 | $-1.32 | $-1.85 | $-3.65 | $-8.95 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 3.4 | 7.5 | 4.8 | · | 14.9 |
| Rasio Cepat | 3.2 | 7.2 | 4.6 | · | 14.7 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-64M | $-58M | $-77M | · | $-36M |
Pemilik institusional (13F) 87 pengaju · $105.2M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
87
Nilai yang dipegang
$105.2M
Posisi baru
12
Posisi yang keluar
9
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 12 (-3 vs Kuartal sebelumnya) | 9 (-2 vs Kuartal sebelumnya) | 26 (+15 vs Kuartal sebelumnya) | 25 (-13 vs Kuartal sebelumnya) | +7.0M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| GordonMD Global Investments LP | $30.174.976 | 10.024.909 | 28,68% | Saham |
| Pfizer Inc | $19.480.773 | 7.032.770 | 18,51% | Saham |
| Laurion Capital Management LP | $14.751.673 | 4.900.888 | 14,02% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.248.751 | 2.075.997 | 5,94% | Saham |
| Atle Fund Management AB | $2.909.041 | 966.459 | 2,76% | Saham |
| VANGUARD GROUP INC | $2.686.133 | 2.335.768 | 2,55% | Saham |
| BlackRock, Inc. | $2.612.481 | 867.934 | 2,48% | Saham |
| Palo Alto Investors LP | $2.601.474 | 864.277 | 2,47% | Saham |
| MARSHALL WACE, LLP | $2.499.936 | 830.544 | 2,38% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $2.324.418 | 772.232 | 2,21% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $1.782.698 | 591.849 | 1,69% | Saham |
| Woodline Partners LP | $1.577.237 | 523.999 | 1,50% | Saham |
| 683 Capital Management, LLC | $1.382.695 | 459.367 | 1,31% | Saham |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1.290.104 | 428.606 | 1,23% | Saham |
| DIADEMA PARTNERS LP | $1.168.482 | 388.200 | 1,11% | Opsi beli |
| Longaeva Partners L.P. | $1.064.282 | 353.582 | 1,01% | Saham |
| Decheng Capital LLC | $983.698 | 326.810 | 0,93% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $911.988 | 302.986 | 0,87% | Saham |
| JANE STREET GROUP, LLC | $873.171 | 290.090 | 0,83% | Saham |
| STATE STREET CORP | $748.999 | 248.837 | 0,71% | Saham |
| MILLENNIUM MANAGEMENT LLC | $701.342 | 233.004 | 0,67% | Saham |
| UBS Group AG | $467.203 | 155.217 | 0,44% | Saham |
| Bank of New York Mellon Corp | $403.328 | 133.996 | 0,38% | Saham |
| NORTHERN TRUST CORP | $373.117 | 123.959 | 0,35% | Saham |
| NewEdge Wealth, LLC | $349.178 | 116.006 | 0,33% | Saham |
| XTX Topco Ltd | $333.926 | 110.939 | 0,32% | Saham |
| TWO SIGMA INVESTMENTS, LP | $252.723 | 83.961 | 0,24% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $244.593 | 81.260 | 0,23% | Saham |
| BANK OF AMERICA CORP /DE/ | $242.197 | 80.464 | 0,23% | Saham |
| JANE STREET GROUP, LLC | $221.837 | 73.700 | 0,21% | Opsi beli |
| STIFEL FINANCIAL CORP | $212.015 | 70.437 | 0,20% | Saham |
| Cable Car Capital, LP | $185.434 | 61.606 | 0,18% | Saham |
| MYDA Advisors LLC | $150.500 | 50.000 | 0,14% | Saham |
| Qube Research & Technologies Ltd | $150.295 | 49.932 | 0,14% | Saham |
| UNIVERSITY OF CHICAGO | $146.680 | 48.731 | 0,14% | Saham |
| CITADEL ADVISORS LLC | $142.424 | 47.317 | 0,14% | Saham |
| Quadrature Capital Ltd | $141.672 | 47.067 | 0,13% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $139.062 | 46.200 | 0,13% | Opsi beli |
| GOLDMAN SACHS GROUP INC | $138.159 | 45.900 | 0,13% | Saham |
| Verdad Advisers, LP | $135.146 | 44.899 | 0,13% | Saham |
| LPL Financial LLC | $131.098 | 43.554 | 0,12% | Saham |
| COMMONWEALTH EQUITY SERVICES, LLC | $127.790 | 42.455 | 0,12% | Saham |
| J. Derek Lewis & Associates Inc. | $126.420 | 42.000 | 0,12% | Saham |
| CITIGROUP INC | $114.997 | 38.205 | 0,11% | Saham |
| SIMPLEX TRADING, LLC | $114.085 | 37.902 | 0,11% | Saham |
| Point72 Asset Management, L.P. | $111.647 | 37.092 | 0,11% | Saham |
| Walleye Capital LLC | $110.702 | 36.778 | 0,11% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $108.887 | 36.175 | 0,10% | Saham |
| MORGAN STANLEY | $100.679 | 33.448 | 0,10% | Saham |
| MACKENZIE FINANCIAL CORP | $79.292 | 26.343 | 0,08% | Saham |
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Lara Sullivan, M.D. ×2 pengajuan | 2 April 2025 | 11,21% | Amandemen | · | SEC |
| Lara Sullivan ×4 pengajuan | 3 April 2024 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 17 orang dalam · 8 pejabat · 9 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Thomas Civik | CEO & Chairman of the Board | 4 Sep. 2026 A | 206.186 | 0 | 0 | $0 |
| Lara Sullivan, M.D. | President ,CEO & CMO | 31 Maret 2025 A | 2.403.882 | 0 | 0 | $0 |
| Connealy Pamela Yanchik | CFO & COO | 31 Maret 2025 A | 1.199.143 | 0 | 0 | $0 |
| Ritu Shah | Chief Operating Officer | 7 Okt. 2021 A | · | 0 | 0 | $0 |
| Jitendra Wadhane | Prin Fin & Acct Officer | 24 Maret 2026 A | 512.882 | 0 | 0 | $0 |
| Ken Kobayashi | Chief Medical Officer | 29 Des. 2023 A | · | 0 | 0 | $0 |
| Jay Feingold | Chief Medical Officer | 24 Maret 2023 A | 730.345 | 0 | 0 | $0 |
| Ronald Herbst | Chief Scientific Officer | 7 Okt. 2021 A | · | 0 | 0 | $0 |
| Jakob Dupont | Direktur | 20 Agu 2026 A | 38.741 | 0 | 1 | $-107.100 |
| Santhosh Palani | Direktur | 24 Maret 2026 A | 6.000 | 0 | 0 | $0 |
| Darren S Cline | Direktur | 24 Maret 2026 A | 251.405 | 0 | 0 | $0 |
| Rachel Humphrey | Direktur | 24 Maret 2026 A | 81.309 | 0 | 3 | $-15.865 |
| Michael A Metzger | Direktur | 24 Maret 2026 A | · | 0 | 0 | $0 |
| Freda C Lewis-Hall | Direktur | 24 Maret 2026 A | 241.405 | 0 | 0 | $0 |
| John L Flavin | Direktur | 24 Maret 2026 A | 413.015 | 0 | 0 | $0 |
| BARCLAYS PLC | Pemilik 10% | 26 April 2022 | · | 0 | 0 | $0 |
| Mark Chin | · | 21 April 2022 S | 0 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 5 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IWC · iShares Trust | 0,04% | 165.468 SH | 11 Sep. 2026 | Harian |
| IBB · iShares Trust | 0,02% | 513.768 SH | 11 Sep. 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 5.892 SH | 2 Okt. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 600.185 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.422.296 SH | 19 Agu 2026 | Harian |
PYXS Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 16 analis
BELI
Target median
$8.00
+273,8%
7 43,8%
Beli Kuat
7 43,8%
Beli
2 12,5%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
9 analis · 2026-10-04Target rata-rata $8.67 +305,0%
← Di bawah semua target
Harga saat ini $2.14
Rendah$6.00
Rata-rata$8.67
Tinggi$19.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | · |
| AVXL | · | -16.5 | -36.1% | -991.4% | · | · |
| VYGR | $232M | -1.9 | -49.5% | -296.5% | -54.4% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 13, 2026